These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
645 related items for PubMed ID: 29497926
1. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B. Ludwig DB, de Camargo LEA, Khalil NM, Auler ME, Mainardes RM. Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926 [Abstract] [Full Text] [Related]
2. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. Moraes Moreira Carraro TC, Altmeyer C, Maissar Khalil N, Mara Mainardes R. J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532 [Abstract] [Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov 15; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
7. Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis. Souza RO, Henrique de Lima T, Oréfice RL, de Freitas Araújo MG, de Lima Moura SA, Magalhães JT, da Silva GR. J Pharm Sci; 2018 Oct 15; 107(10):2674-2685. PubMed ID: 29940181 [Abstract] [Full Text] [Related]
11. Patterns of amphotericin B killing kinetics against seven Candida species. Cantón E, Pemán J, Gobernado M, Viudes A, Espinel-Ingroff A. Antimicrob Agents Chemother; 2004 Jul 15; 48(7):2477-82. PubMed ID: 15215097 [Abstract] [Full Text] [Related]
13. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest. Chiu YS, Chang SC, Hsueh PR, Wang JL, Sun HY, Chen YC. J Microbiol Immunol Infect; 2006 Aug 15; 39(4):335-41. PubMed ID: 16926981 [Abstract] [Full Text] [Related]
14. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates. Thanathanee O, Miller D, Ringel DM, Schaffner CP, Alfonso EC, O'Brien TP. J Ocul Pharmacol Ther; 2012 Dec 15; 28(6):589-92. PubMed ID: 22788845 [Abstract] [Full Text] [Related]
18. Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model. Beredaki M-I, Arendrup MC, Pournaras S, Meletiadis J. Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0022524. PubMed ID: 38958455 [Abstract] [Full Text] [Related]
19. [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains]. Yalçin B, Kalkanci A, Gürelik F, Fidan I, Kustimur S, Ozdek S. Mikrobiyol Bul; 2010 Jan 07; 44(1):65-70. PubMed ID: 20455400 [Abstract] [Full Text] [Related]